New Delhi, February 27 Drug maker Lupin announced on Friday that it has received an Establishment Inspection Report (EIR) from the US health regulator for its manufacturing facility in Goa.The company stated that it has received the EIR with a satisfactory Voluntary Action Indicated (VAI)...
New Delhi, February 14 Piramal Pharma has stated that the US health regulator has issued a Form 483 with four observations after inspecting its manufacturing plant based in Telangana.The US Food and Drug Administration (USFDA) conducted an inspection of the company's plant in Digwal...
compliance
digwal
drug maker
food, drug and cosmetic (fd&c) act
form 483
inspection
manufacturing plant
pharmaceutical inspection
piramal pharma
regulatory filing
telangana
us food and drug administration (usfda)
usfda inspection
voluntaryactionindicated (vai)